Peptide record

TPDB18217

Antibacterial Anticancer Toxicity standard
40 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18217
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 40-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
ATCDLLSPFKVGHAACAAHCIARGKRGGWCDGRAVCNCRK
Physicochemical Analysis
C175H285N61O48S6
EQMY
A
4203.93
8.92
9
2
14
+5
4.88
-0.042
61.25
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
5875
139.75
9
Residue Composition
number
7
A
4
R
1
N
2
D
6
C
0
E
0
Q
5
G
2
H
1
I
2
L
3
K
0
M
1
F
1
P
1
S
1
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 7 R: 4 N: 1 D: 2 C: 6 E: 0 Q: 0 G: 5 H: 2 I: 1 L: 2 K: 3 M: 0 F: 1 P: 1 S: 1 T: 1 W: 1 Y: 0 V: 2
Chemical Descriptors
40
C175H285N61O48S6
4203.93
8.92
+5
4.88
-0.042
Evidence Records 6 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.95 µM

Target

Staphylococcus aureus CVCC 546

Source & Reference

NA

Other

Active against Gram+ S. aureus CVCC 546 (MIC 0.95 uM), S. epidermidis ATCC 12228 (MIC 1.91 uM), S. pneumoniae CVCC 2350 (MIC 0.95 uM), and S. s
Evidence 2 Activity

Activity

MIC
Antibacterial
1.91 µM

Target

Staphylococcus epidermidis ATCC 12228

Source & Reference

NA

Other

Active against Gram+ S. aureus CVCC 546 (MIC 0.95 uM), S. epidermidis ATCC 12228 (MIC 1.91 uM), S. pneumoniae CVCC 2350 (MIC 0.95 uM), and S. suis CVCC 3928 (MIC 0.95 uM), stronger tha
Evidence 3 Activity

Activity

MIC
Antibacterial
0.95 µM

Target

S. pneumoniae CVCC 2350

Source & Reference

NA

Other

against Gram+ S. aureus CVCC 546 (MIC 0.95 uM), S. epidermidis ATCC 12228 (MIC 1.91 uM), S. pneumoniae CVCC 2350 (MIC 0.95 uM), and S. suis CVCC 3928 (MIC 0.95 uM), stronger than the WT DLP4 (see AP2548). Not good at
Evidence 4 Activity

Activity

MIC
Antibacterial
0.95 µM

Target

S. suis CVCC 3928

Source & Reference

NA

Other

uM), S. epidermidis ATCC 12228 (MIC 1.91 uM), S. pneumoniae CVCC 2350 (MIC 0.95 uM), and S. suis CVCC 3928 (MIC 0.95 uM), stronger than the WT DLP4 (see AP2548). Not good at Gram- E-coli ATCC 25922 or K88 (MIC
Evidence 5 Activity

Activity

MIC
Antibacterial
>30.5 µM

Target

S. pullorum CVCC 533

Source & Reference

NA

Other

than the WT DLP4 (see AP2548). Not good at Gram- E-coli ATCC 25922 or K88 (MIC >30.5 uM), S. pullorum CVCC 533 (MIC >30.5 uM), and S. enteritidis CVCC 3377 (MIC >30.5 uM, i.e., >128 ug/ml).
Evidence 6 Activity

Activity

0.38% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
0.38% Hemolysis | 128 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546. | Front Microbiol | 2020